Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Xact Bear XACTBEAR Apr 24, 2025 18.09 -0.41   
 Xact Bear 2 XACTBEAR2 Apr 24, 2025 8.98 -0.65   
 Xact Bull XACTBULL Apr 24, 2025 729.10 +0.40   
 Xact Bull 2 XACTBULL2 Apr 24, 2025 1 528.60 +0.57   
 Xact Högutdelande XACTHDIV Apr 24, 2025 142.14 0.00   
 Xact Norden XACTNORDEN Apr 24, 2025 232.45 +0.06   
 Xact OMXS30 XACTOMXS30 Apr 24, 2025 344.95 +0.44   
 XANO Industri B XANOB Apr 24, 2025 42.45 -5.77   
 Xbrane Biopharma XBRANE Apr 24, 2025 0.19 +4.07   
 Xintela XINT Apr 24, 2025 0.33 -5.14   
 XMReality XMR Apr 24, 2025 0.02 -1.28   
 Xoma XOMB Apr 24, 2025 0.60 -20.00   
 XP Chemistries XPC Apr 24, 2025 0.32 +0.63   
 Xspray Pharma XSPRAY Apr 24, 2025 37.05 -2.50   
 Xvivo Perfusion XVIVO Apr 24, 2025 313.80 +6.88   
 Yubico AB YUBICO Apr 24, 2025 189.50 -0.26   
 Zaplox ZAPLOX Apr 24, 2025 1.00 -0.20   
 Zenergy B ZENZIPB Apr 24, 2025 0.89 -0.67   
 Zenicor ZENI Apr 24, 2025 2.94 -5.16   
 Zinzino B ZZB Apr 24, 2025 162.20 -1.22   
 Zoomability ZOOM Apr 24, 2025 1.23 -2.78   
 Öresund ORES Apr 24, 2025 118.40 +0.78   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.